Section Arrow
Quote
LEXX.NASDAQ
- Lexaria Bioscience Corp
Quotes are at least 15-min delayed:2025/01/11 18:01 EST
Last
 2.16
-0.05 (-2.26%)
Day High 
2.28 
Prev. Close
2.21 
1-M High
2.54 
Volume 
59.94K 
Bid
2.09
Ask
2.19
Day Low
2.12 
Open
2.22 
1-M Low
2 
Market Cap 
38.57M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.24 
20-SMA 2.24 
50-SMA 2.25 
52-W High 6.85 
52-W Low 1.36 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.47/-0.34
Enterprise Value
38.68M
Balance Sheet
Book Value Per Share
0.46
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
464.28K
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed：2025/01/11 18:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.